Home Nucleus Pharmaceuticals U.S. Induced Pluripotent Stem Cells (iPSCs) Market to 2032

U.S. Induced Pluripotent Stem Cells (iPSCs) Market to 2032

Overview

The U.S. Induced Pluripotent Stem Cells (iPSCs) Market is expected to reach a 1,168.50 USD Million by 2032 and is projected to grow at a CAGR of 12.41% from 2025 to 2032.

Revenue, 2024 (USD Million)
556.44
Forecast, 2032 (USD Million)
1,168.50
CAGR, 2024 - 2032
12.41%
Report Coverage
U.S.

U.S. Induced Pluripotent Stem Cells (iPSCs) Market 2018-2032 USD Million

U.S. Induced Pluripotent Stem Cells (iPSCs) Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 556.44 USD Million
  • Projected Market Size (2032): 1,168.50 USD Million
  • CAGR (2025-2032): 12.41%

Key Findings of U.S. Induced Pluripotent Stem Cells (iPSCs) Market

  • The U.S. Induced Pluripotent Stem Cells (iPSCs) Market was valued at 556.44 USD Million in 2024.
  • The U.S. Induced Pluripotent Stem Cells (iPSCs) Market is likely to grow at a CAGR of 12.41% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Human iPSCs in Type Segment accounted for the largest share of the market with a revenue of 391.36 USD Million
  • The fastest growing segment Biotechnology & Pharmaceutical Companies in End User Segment grew Fastest with a CAGR of 15.05% during the forecast period from 2024 to 2032.

U.S. Induced Pluripotent Stem Cells (iPSCs) Market Scope

U.S. Induced Pluripotent Stem Cells (iPSCs) Market Segmentation & Scope
Cell Source
  • Blood Cells
  • Skin Cells
Type
  • Mouse iPSCs
  • Human iPSCs
Application
  • Others
  • 3D Bioprinting
  • Stem Cell Banking
  • Toxicology Screening
  • Regenerative Medicine
  • Cellular Therapy
  • Disease Modelling
  • Academic Research
  • Drug Discovery And Development
End User
  • Others
  • Diagnostic Laboratories
  • Research Laboratories
  • Biotechnology & Pharmaceutical Companies
Distribution Channel
  • Retail Sales
  • Direct Tender
Product
  • Instruments
  • Services
  • Consumables & Kits

U.S. Induced Pluripotent Stem Cells (iPSCs) Market Data Coverage Insights

Study Period 2024-2032
Base Year 2022
Unit Revenue in USD Million
Market Value in 2024 556.44 USD Million
Market Value in 2032 1,168.50 USD Million
CAGR (2025-2032) 12.41%
Historic Data 2016-2023
Market Segments Covered Cell Source,Type,Application,End User,Distribution Channel,Product

Regional Insights:

  • Leading Market (2024-2032): U.S., leading in terms of revenue 556.44 USD Million in 2024
    • Key Country: U.S., leading in terms of revenue with value of 556.44 USD Million in 2024.

Segments and Scope

  • U.S. Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Cell Source
    • Skin Cells is the largest segment in U.S. Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 352.98 USD Million in the year 2024.
    • Skin Cells is the Fastest growing segment in U.S. Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 12.57 % in forecast period 2025-2032.
  • U.S. Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Type
    • Human iPSCs is the largest segment in U.S. Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 391.36 USD Million in the year 2024.
    • Human iPSCs is the Fastest growing segment in U.S. Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 13.28 % in forecast period 2025-2032.
  • U.S. Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Application
    • Drug Discovery And Development is the largest segment in U.S. Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 126.36 USD Million in the year 2024.
    • Academic Research is the Fastest growing segment in U.S. Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 13.27 % in forecast period 2025-2032.
  • U.S. Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By End User
    • Biotechnology & Pharmaceutical Companies is the largest segment in U.S. Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 276.87 USD Million in the year 2024.
    • Biotechnology & Pharmaceutical Companies is the Fastest growing segment in U.S. Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 15.05 % in forecast period 2025-2032.
  • U.S. Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in U.S. Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 369.15 USD Million in the year 2024.
    • Direct Tender is the Fastest growing segment in U.S. Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 13.55 % in forecast period 2025-2032.
  • U.S. Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Product
    • Consumables & Kits is the largest segment in U.S. Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 285.46 USD Million in the year 2024.
    • Consumables & Kits is the Fastest growing segment in U.S. Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 13.60 % in forecast period 2025-2032.

U.S. Induced Pluripotent Stem Cells (iPSCs) Market Company Share Analysis

 
Company Name Company Share Analysis
Merck KGaA
Lonza
Thermo Fisher Scientific Inc.
Evotec SE
FUJIFILM Corporation
U.S. Induced Pluripotent Stem Cells (iPSCs) Market Company Share Analysis

U.S. Induced Pluripotent Stem Cells (iPSCs) Market Geographical Sales Distribution, 2018-2032 USD Million

U.S. Induced Pluripotent Stem Cells (iPSCs) Market Geographical Sales Distribution, 2018-2032 USD Million

U.S. Induced Pluripotent Stem Cells (iPSCs) Market Company Profiling

U.S. Induced Pluripotent Stem Cells (iPSCs) Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market
Middle East & Africa Cold Sore Treatment Market
North America Cold Sore Treatment Market
Europe Cold Sore Treatment Market
Asia-Pacific Cold Sore Treatment Market
Argentina Cold Sore Treatment Market
Australia Cold Sore Treatment Market
Austria Cold Sore Treatment Market
Belgium Cold Sore Treatment Market
Brazil Cold Sore Treatment Market
Frequently Asked Questions
The U.S. Induced Pluripotent Stem Cells (iPSCs) Market is segmented based on Segmentation Cell Source,Type,Application,End User,Distribution Channel,Product.
U.S. Induced Pluripotent Stem Cells (iPSCs) Market was valued at USD 556.44(Revenue in USD Million) in 2022.
U.S. Induced Pluripotent Stem Cells (iPSCs) Market is projected to grow at a CAGR of 12.41% during the forecast period of 2024 to 2032.
The Human iPSCs segment is expected to dominate the U.S. Induced Pluripotent Stem Cells (iPSCs) Market, holding a largest market share of 391.36 USD Million in 2024

Coming Soon....

U.S. Induced Pluripotent Stem Cells (iPSCs) Market Scope

U.S. Induced Pluripotent Stem Cells (iPSCs) Market Segmentation & Scope
Cell Source
  • Blood Cells
  • Skin Cells
Type
  • Mouse iPSCs
  • Human iPSCs
Application
  • Others
  • 3D Bioprinting
  • Stem Cell Banking
  • Toxicology Screening
  • Regenerative Medicine
  • Cellular Therapy
  • Disease Modelling
  • Academic Research
  • Drug Discovery And Development
End User
  • Others
  • Diagnostic Laboratories
  • Research Laboratories
  • Biotechnology & Pharmaceutical Companies
Distribution Channel
  • Retail Sales
  • Direct Tender
Product
  • Instruments
  • Services
  • Consumables & Kits
Frequently Asked Questions
The U.S. Induced Pluripotent Stem Cells (iPSCs) Market is segmented based on Segmentation Cell Source,Type,Application,End User,Distribution Channel,Product.
U.S. Induced Pluripotent Stem Cells (iPSCs) Market was valued at USD 556.44(Revenue in USD Million) in 2022.
U.S. Induced Pluripotent Stem Cells (iPSCs) Market is projected to grow at a CAGR of 12.41% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Induced Pluripotent Stem Cells (iPSCs) Market for final year is USD 1,168.50 (USD Million).

U.S. Induced Pluripotent Stem Cells (iPSCs) Market Company Profiling

U.S. Induced Pluripotent Stem Cells (iPSCs) Market Company Profiling
Frequently Asked Questions
The U.S. Induced Pluripotent Stem Cells (iPSCs) Market is segmented based on Segmentation Cell Source,Type,Application,End User,Distribution Channel,Product.
U.S. Induced Pluripotent Stem Cells (iPSCs) Market was valued at USD 556.44(Revenue in USD Million) in 2022.
U.S. Induced Pluripotent Stem Cells (iPSCs) Market is projected to grow at a CAGR of 12.41% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Induced Pluripotent Stem Cells (iPSCs) Market for final year is USD 1,168.50 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.